Artificial intelligence (AI) has demonstrated remarkable potential in reshaping modern drug discovery, yet its widespread adoption is hindered by fragmented tools, high technical barriers, and the lack of user-friendly interfaces. Here, we present WeMol, an AI-driven one-stop molecular computing platform designed to streamline early-stage drug discovery. WeMol integrates a series of modules, covering molecular similarity search, structure-based and AI-enhanced docking, ADMET prediction, molecular generation, and molecular dynamics simulations. The platform features a zero-code, cloud-based interface that enables researchers without programming expertise to construct and execute comprehensive computational workflows. By integrating advanced AI algorithms with practical applications, WeMol lowers the entry barrier for nonexperts and provides a versatile, accessible, and reproducible solution to accelerate early drug design and discovery.
Liu et al. (Tue,) studied this question.